Drug Type Small molecule drug |
Synonyms EPINEPHRINE BITARTRATE/LIDOCAINE HYDROCHLORIDE, Iontocaine, Lidocaton + [3] |
Action blockers, agonists |
Mechanism SCNA blockers(Sodium voltage-gated channel alpha subunits blockers), adrenergic receptor agonists(Adrenergic receptors agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (19 Nov 1948), |
Regulation- |
Molecular FormulaC14H23ClN2O |
InChIKeyIYBQHJMYDGVZRY-UHFFFAOYSA-N |
CAS Registry73-78-9 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | Epinephrine/Lidocaine Hydrochloride | - |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Pain | United States | 26 Oct 2004 | |
| Dermatophilosis | United States | 06 May 2004 | |
| Visible Lesion | United States | 06 May 2004 | |
| Anesthesia | United States | 19 Nov 1948 | |
| Anesthesia | United States | 19 Nov 1948 |
Phase 4 | 75 | (Lidocaine+Epinephrine (vs Ropivacaine)) | fgszbcaotv(lypxvimeub) = vmpqflyncc qdpnpbdpeg (mqcelvzkaq, 27.48) View more | - | 19 Sep 2024 | ||
(Ropivacaine (vs Lidocaine+Epinephrine)) | fgszbcaotv(lypxvimeub) = adnotfywpn qdpnpbdpeg (mqcelvzkaq, 22.53) View more | ||||||
Phase 4 | 46 | (Topical Lidocaine and Bupivacaine Alone) | vfwmdbvdiv(tuoynkrzvn) = jiynaxrkrf vbhvagxuey (pglflpuikz, uzarlxshun - wxjpccoemz) View more | - | 26 Jun 2024 | ||
Recombinant Human Thrombin+Lidocaine Hydrochloride with Epinephrine+Bupivacaine Hydrochloride with Epinephrine (Topical Lidocaine and Bupivacaine With Thrombin) | vfwmdbvdiv(tuoynkrzvn) = osmydrwwbs vbhvagxuey (pglflpuikz, gmwiersjnp - nwvbegfprl) View more | ||||||
Not Applicable | 88 | (Buffered Lidocaine) | oqmcxjeios(gromemspcg) = woqmzotjmc ntoytktlxd (ywjfoeaxsy, 60.1) View more | - | 12 Oct 2020 | ||
(Nonbuffered Lidocaine) | oqmcxjeios(gromemspcg) = adzfsimrtw ntoytktlxd (ywjfoeaxsy, 50.5) View more | ||||||
Phase 2 | - | 40 | Iontophoresis System+lidocaine/epinephrine solution (Active Tymbion Iontophoresis) | cvirriined(zjuixgugqp) = xjlqhpxvgt gjbnhvhguu (prxpuojcua, 13.1) View more | - | 06 Jan 2020 | |
epinephrine+Tymbion Lidocaine (Sham Tymbion Iontophoresis) | cvirriined(zjuixgugqp) = xnuuihdrnu gjbnhvhguu (prxpuojcua, 24.1) View more | ||||||
Not Applicable | 68 | (Oxymetazoline 0.05%) | mnnsbltfjx(ngzsylrrej) = bbcgiczrjy nubtimflir (hptqkokyyl, 6.8) View more | - | 02 Oct 2018 | ||
(Phenylephrine 0.25%) | mnnsbltfjx(ngzsylrrej) = ineihvwdao nubtimflir (hptqkokyyl, 5.8) View more | ||||||
Not Applicable | epinephrine | 9 | 2% lidocaine with epinephrine 1:100,000 | krwjauxsax(nlfssyexjg) = ivleoylxah pmzanreqsv (yqwfzbguwc ) | - | 01 Sep 1990 | |
lidocaine alone | krwjauxsax(nlfssyexjg) = exxneydwnh pmzanreqsv (yqwfzbguwc ) |





